Related Experiment Video
Updated: Jul 21, 2026
07:47
The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire
Published on: December 23, 2014
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
M M Bern1, J J Lokich, S R Wallach
1New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts.
Annals of Internal Medicine
|March 15, 1990
Summary
Low-dose warfarin (1 mg) effectively prevents thrombosis in patients with central venous catheters. This prophylaxis was achieved without increasing bleeding risk, suggesting a safe and beneficial approach for at-risk individuals.
Area of Science:
- Vascular Medicine
- Pharmacology
- Thrombosis Research
Background:
- Central venous catheters are essential for chronic medical conditions but pose a risk of thrombosis.
- Thrombosis associated with central venous catheters can lead to significant morbidity.
Purpose of the Study:
- To evaluate the efficacy of very low-dose warfarin in preventing thrombosis in patients with central venous catheters.
- To assess the safety profile of low-dose warfarin regarding hemorrhagic complications.
Main Methods:
- A prospective, randomized study involving 121 patients at risk for catheter-related thrombosis.
- Patients received either 1 mg of warfarin or no anticoagulant, starting 3 days before catheter insertion for 90 days.
- Venograms were performed to diagnose thrombosis.
Main Results:
- Warfarin significantly reduced the incidence of venogram-proven thrombosis (4/42 vs. 15/40, P < 0.001).
- No significant changes in coagulation values were observed with low-dose warfarin.
- The treatment was not associated with an increased risk of bleeding.
Conclusions:
- Very low-dose warfarin (1 mg) is effective in preventing central venous catheter-related thrombosis.
- This prophylactic strategy appears safe, with no increased hemorrhagic risk.
- The findings suggest potential applicability to other patient populations requiring thrombosis prophylaxis.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...